720
Participants
Start Date
June 5, 2025
Primary Completion Date
December 31, 2028
Study Completion Date
December 31, 2028
CHIKV VLP vaccine
CHIKV VLP vaccine is comprised of chikungunya virus virus-like particles (CHIKV VLP), adsorbed on aluminum hydroxide (Alhydrogel®) adjuvant 2%
Placebo
Placebo is comprised of formulation buffer
NOT_YET_RECRUITING
Caribbean Medicine Center, San Juan
NOT_YET_RECRUITING
Emerson Clinical Research Institute- DC, Washington D.C.
NOT_YET_RECRUITING
Acevedo Clinical Research, Miami
ACTIVE_NOT_RECRUITING
Hope Research Network, Miami
NOT_YET_RECRUITING
Cincinnati Children's Hospital Medical Center, Cincinnati
RECRUITING
Velocity Clinical Research-Omaha, Omaha
RECRUITING
KidCare Pediatrics, Beaumont
RECRUITING
Velocity Clinical Research - Salt Lake City, West Jordan
RECRUITING
ARK Clinical Research, LLC, Fountain Valley
Lead Sponsor
Bavarian Nordic
INDUSTRY